Report Description Table of Contents In 2020, the Global Minimally Invasive Surgical Instruments Market share was USD 20.878 billion. It is predicted to reach USD 41.767 billion by 2030, representing a CAGR of 7.214 percent throughout the forecasted period. Minimally Invasive Surgery (MIS) is a process that involves the conduction of surgical incisions for the reduction of trauma to the body. The surgery is performed by the usage of thin needles and an endoscope. MIS is widely used for cancer diagnostics, kneeand hip replacements, gallbladder problems, treatment of spinal disorders, heart and lung operations, etc. Cancer is one of the pivotal causes of death across the globe. According to GLOBOCAN 2020, the number of cancer cases rose to 19.3 Mn, and the total number of fatalities due to cancer reached a landmark of 10 Mn across the globe. According to THE CENTER (Orthopaedic and Neurosurgical Care and Research), in the United States,almost 1 Mn knee and hip replacement surgeries are performed each year. By 2030, the total number of knee replacement surgeries is estimated to grow by almost 67.3% (i.e., 3.5Mn procedures per year). In addition, approximately 60% of all knee implant surgeries are performed on women. Also, over 90 % of the people who had undergone knee replacement surgeries experienced a drastic reduction in knee pain. Also, the Minimally Invasive Glaucoma Surgery (Migs) devices help in reducing eye pressure along with the added benefits of a faster recovery time, which in turn is fuelling the overall market growth. All of the aforementioned statistics are highly expected to propel the overall market growth during the forecasted period of 2020-2030. Market Dynamics: - Market Drivers: - Rising prevalence of the total number of surgeries across the globe. The continuous increase in the number of MI surgeries worldwide such as(robotic surgery, Adrenalectomy, Brain surgery, Colectomy, Gallbladder surgery (cholecystectomy), Heart surgery, Kidney transplant, Nephrectomy (kidney removal), Spine surgery, Splenectomy, Cancer surgery, Colon and rectal surgery, Endovascular surgery, Gastroenterologic surgery, Neurosurgery, Orthopaedic surgery,Thoracic surgery, Otolaryngology, head and neck surgery, Urologic surgery, Robotic heart surgery, Minimally invasive heart surgery, Robotic hysterectomy, Robotic myomectomy, Robotic surgery, Non-robotic minimally invasive surgery (endoscopic surgery), weight loss surgery, Arthroscopic surgery, Natural orifice transluminal endoscopic surgery (NOTES), Parathyroidectomy, Video-assisted thoracoscopic surgery (VATS), repair of heart valves, supracervical hysterectomy, exploratory laparoscopy, percutaneous discectomy, minimally invasive cardiac surgery, minimally invasive knee replacement, robotic myomectomy, minimally invasive hip replacement, minimally invasive lumbar decompression, laparoscopic supracervical hysterectomy, minimally invasive mitral valve repair, minimally invasive aortic valve replacement, minimally invasive achilles bone spur surgery, minimally invasive back surgery) is one of the most major reasons that is driving the overall growth of the market. In accordancewith the National Library of Medicine, approximately 310 Mn surgeries are performed across the world each year, nearly 40 to 50 Mn in the United States and 20Mn in Europe. Apart from the rise of surgical procedures, the increasing geriatric population worldwide is also facilitating the Minimally Invasive Surgical Instruments Market growth extensively since geriatric people are more prone to chronic diseases like cardiovascular, orthopaedic, and ophthalmic disorders. Besides the growth of the geriatric population, the rising prevalence of several diseases like Hiatal hernia, gastroesophageal reflux disease, Benign prostatic hyperplasia (BPH), Median arcuate ligament syndrome (MALS), Rectal cancer, atrial fibrillation, mitral valve prolapse, bladder cancer, kidney cancer, etc. and some pivotal MIS tests like Bronchoscopy, Hysteroscopy, Sigmoidoscopy, and Vaginal access are driving the market growth extensively across the world. Restraints: -Expensive MIS and late FDA approvals The higher cost of MIS is the major factor that is widely obstructing the market growth worldwide. The total healthcare cost (both direct and indirect) associated with MIS-TLIF sums up to USD 40000. Also, the huge delays in FDA approvals for launching the MIS instruments into the market are restraining the overall market growth widely. Opportunities: -Rapid technological advancements and a huge demand for MIS instruments in the Asia Pacific region The rapid advancements of the minimally invasive surgical technologies and a huge demand for the MIS instruments such as new surgical robots (Da Vinci Surgical Robot), and highly upgraded image guiding systems (ultrasound medical imaging, MRI, CT scan) are increasing continuously across the globe and are expected to grow exponentially in the future.According to Undark Magazine, in 2018, more than 1 million procedures were performed worldwide with the da Vinci Surgical Robot and approximately 3 in 4 of those procedures were performed in the United States itself.Moreover, according to JAMA (Journal of American Medical Association), the usage of robotic surgery for all general surgical procedures increased from 1.8% in 2012 to a staggering 15.1% in 2018. Also, the market of MIS instruments is growing rapidly in the Asia-Pacific region owing to its business-friendly environment and lenient regulatory policies, which in turn has drawn the market leaders to invest in MIS surgical instruments in this region in the future. Global Minimally Invasive Surgical Instruments Market: - Analysis of different Segmentations: The segmentation of the Global MinimallyInvasive Surgical Instruments Market is performed based on Product, Surgery Type, End-User, and Regions. Based on Product Handheld Instruments Cutting Instruments Inflation Devices Electrosurgical & Electrocautery Instruments Guiding Devices Others Based on Surgery Type Cardiothoracic Surgery Orthopaedic Surgery Gastrointestinal Surgery Cosmetic Surgery Gynaecological Surgery Urological Surgery Others Based on End-User Hospitals and Speciality Clinics Ambulatory Surgery Centers (ASCs) Others Based on Regions: North America US Mexico Canada Rest of North America Europe Switzerland Russia France Germany U.K Finland Turkey Netherlands Belgium Spain Italy Rest of Europe Asia Pacific China India Indonesia South Korea Thailand Japan Singapore Malaysia Philippines Australia Rest of Asia-Pacific LAMEA Brazil Saudi Arabia Uruguay Argentina Rest of LAMEA Based on Product, the ‘Handheld Instruments’ dominated the market in 2020 with a CAGR of 7.134 % and overall revenue of USD 4.683 billion. The increasing number of surgical procedures, lower cost of laparoscopic handheld surgical devices, and the rising technological innovations in handheld instruments are some of the pivotal factors that are fuelling the growth of this segment. Based on Surgery Type, the ‘Cardiothoracic Surgery’ dominated the market in 2020 with a steady CAGR. The factors such as an increase in the number of heart diseases, rising awareness of MIS instruments, and the increase of coronary and percutaneous cardio interventions are driving the overall growth of this segment. According to iData Research, the total number of cardiac surgeries each year exceeds 9,00,000 in the United States. Based on End-User, the ‘Hospitals and Speciality Clinics’ segment dominated the market significantly in 2020. The continuous increase in the number of MI surgeries in hospitals due to the presence of high-skilled healthcare professionals is stimulating the growth of this segment. Based on Region, North America dominated the market in 2020, with a CAGR of 7.732% and overall revenue of 6.934 billion. A rise in the number of chronic diseases, highly developed healthcare infrastructure and systems, and rise of expenditure in the healthcare sector by the government is accelerating the growth of the market in this region. Global MIS Instruments Market: Competitive Landscape The competitive landscape analysis provides adequate details about the pivotal competitors that exist in the market environment. The comparison is performed based on market initiatives, company overview, total revenue generation, market potential, investment in R&D, global presence, company financials, the capacity of production, company strengths and weaknesses, production sites and facilities, etc. The major players that are inculcated in the Minimally Invasive Surgical Instruments Market report are: Medtronic plc Stryker Corporation Johnson & Johnson Smith & Nephew plc Abbott Laboratories, Inc. B. Braun Melsungen AG CONMED Corporation Boston Scientific Corporation Zimmer Biomet Holdings, Inc. Becton, Dickinson and Company The Cooper Companies Inc. HOYA Corporation Surgical Innovations Group plc Koninklijke Philips N.V. FUJIFILM Holdings Corporation KARL STORZ SE & Co. KG Applied Medical Resources Corporation STRAUSS SURGICAL KLS Martin Group Scanlan International, Inc. TROKAMED GmbH Wexler Surgical AMNOTEC International Medical GmbH EndoMed Systems GmbH Surgical Holdings Global Minimally Invasive Surgical Instruments Market: Recent Developments On Sep 30th, 2021, Medtronic expanded the MI Spine Surgery Ecosystem with the next generation of spinal technologies and became the only organization to provide combined data (i.e., the combination of biologics, spinal implants, robotics, navigation, and AI-powered data) to the surgeons worldwide. On Nov 19th, 2020, Johnson and Johnson unveiled its new Robot-Assisted Surgical System for providing more control and flexibility in the minimally invasive surgery processes. It contains a Zero-footprint design for enabling patient access and thus improving the overall workflow. On Oct 7th, 2020, Stryker Corporation proudly announced that it expanded its lateral spine portfolio by launching the Niagra Lateral Access System. The system plays a vital role in providing an integrated portfolio of MI lateral solutions to treat various kinds of spinal deformities among skeletally matured patients. Most crucial MIS Instruments that are developed by the leading companies: - PRODUCT FUNCTION COMPANY ANTHEM Total Knee System It contains advanced tibial and femoral anatomic designs for facilitating the anatomic implant for all patients worldwide and also helps in improving the surgical method of knee prosthesis. Smith & Nephew Snowden-Pencer Ergonomic Laparoscopic Instruments It contains a large variety of jaw patterns and ergonomic handles to meet all the MIS needs with precision and comfort. Becton, Dickinson and Company Anchor Tissue Retrieval System Provides comprehensive product offerings for safe and effective specimen retrieval according to the surgeon’s need. CONMEDCorporation Clean Coat Laparoscopic Electrodes Helps in optimization of the overall performance in laparoscopic procedures. Medtronic Frequently Asked Question About This Report na 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Minimally Invasive Surgical Instruments Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Minimally Invasive Surgical Instruments Market 4.2.1 Global Minimally Invasive Surgical Instruments market, 2020 – 2028 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global Minimally Invasive Surgical Instruments market, by Region, 2020 - 2028 (USD Million) 4.4 Product Business Analysis 4.4.1 Global Minimally Invasive Surgical Instruments market, By Product, 2020 - 2028 (USD Million) 4.5 End-User Business Analysis 4.5.1 Global Minimally Invasive Surgical Instruments market, By End-User, 2020 - 2028 (USD Million) 4.5 Surgery Type Business Analysis 4.5.1 Global Minimally Invasive Surgical Instruments market, By Surgery Type, 2020 - 2028 (USD Million) 4.6 Value Chain Analysis 4.7 Market Variable Analysis 4.7.1 Market Drivers Analysis 4.7.2 Market Restraints Analysis 4.8 Business Environment Analysis Tool 4.8.1 Minimally Invasive Surgical Instruments market PEST analysis 4.8.2 Minimally Invasive Surgical Instruments market Porter’s analysis 4.9 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Minimally Invasive Surgical Instruments Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Technology Analysis 5.11.1. Trends in Technology (2014-2020) 5.11.2. Trends in Technology (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Minimally Invasive Surgical Instruments Manufacturing Sites, Area Served, Product 6.3. Minimally Invasive Surgical Instruments Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Minimally Invasive Surgical Instruments Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2020-2028) 7.3. Handheld Instruments 7.3.1. Handheld Instruments market, 2020 - 2028 (USD Million) 7.4. Cutting Instruments 7.4.1. Cutting Instruments market, 2020 - 2028 (USD Million) 7.4. Inflation Devices 7.4.1. Inflation Devices market, 2020 - 2028 (USD Million) 7.4. Electrosurgical & Electrocautery Instruments 7.4.1. Electrosurgical & Electrocautery Instruments market, 2020 - 2028 (USD Million) 7.4. Guiding Devices 7.4.1. Guiding Devices market, 2020 - 2028 (USD Million) 7.4. Others 7.4.1. Others market, 2020 - 2028 (USD Million) 8. Global Minimally Invasive Surgical Instruments Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2020-2028) 8.3. Hospitals and Speciality Clinics 8.3.1. Hospitals and Speciality Clinics market, 2020 - 2028 (USD Million) 8.4. Ambulatory Surgery Centers (ASCs) 8.4.1. Ambulatory Surgery Centers (ASCs) market, 2020 - 2028 (USD Million) 8.5. Others 8.5.1. Others market, 2020 - 2028 (USD Million) 9. Global Surgery Type Market: By Surgery Type Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2020-2028) 9.3. Cardiothoracic Surgery 9.3.1. Cardiothoracic Surgery market, 2020 - 2028 (USD Million) 9.4. Orthopaedic Surgery 9.4.1. Orthopaedic Surgery market, 2020 - 2028 (USD Million) 9.5. Gastrointestinal Surgery 9.5.1. Gastrointestinal Surgery market, 2020 - 2028 (USD Million) 9.6. Cosmetic Surgery 9.6.1. Cosmetic Surgery market, 2020 - 2028 (USD Million) 9.7. Gynaecological Surgery 9.7.1. Gynaecological Surgery market, 2020 - 2028 (USD Million) 9.8. Urological Surgery 9.8.1. Urological Surgery market, 2020 - 2028 (USD Million) 9.9. Others 9.9.1. Others market, 2020 - 2028 (USD Million) 9. Global Minimally Invasive Surgical Instruments Market: Regional Outlook 9.1 North America 9.1.1. North America Minimally Invasive Surgical Instruments market, By Product, 2020 - 2028 (USD Million) 9.1.4. North America Minimally Invasive Surgical Instruments market, By End-User, 2020 - 2028 (USD Million) 9.1.5. North America Minimally Invasive Surgical Instruments market, by Country, 2020 - 2028 (USD Million) 9.1.4.1. U.S. 9.1.4.1.1. U.S. Minimally Invasive Surgical Instruments market, By Product, 2020 - 2028 (USD Million) 9.1.4.2. Canada 9.1.4.2.1. Canada Minimally Invasive Surgical Instruments market, By Product, 2020 - 2028 (USD Million) 9.1.4.2.2. Canada Minimally Invasive Surgical Instruments market, By Region, 2020 - 2028 (USD Million) 9.1.4.2.3. Canada Minimally Invasive Surgical Instruments market, by End-Users, 2020 - 2028 (USD Million) 9.2. Europe 9.2.1. Europe Minimally Invasive Surgical Instruments market, By Product, 2020 - 2028 (USD Million) 9.2.2. Europe Minimally Invasive Surgical Instruments market, by By End-User, 2020 - 2028 (USD Million) 9.2.5. Europe Minimally Invasive Surgical Instruments market, by country, 2020 - 2028 (USD Million) 9.2.4.1 U.K. 9.2.4.1.1. U.K. Minimally Invasive Surgical Instruments market, By Product, 2020 - 2028 (USD Million) 9.2.4.1.2. U.K. Minimally Invasive Surgical Instruments market, By End-Users, 2020 - 2028 (USD Million) 9.2.4.1.3. U.K. Minimally Invasive Surgical Instruments market, by Region, 2020 - 2028 (USD Million) 9.2.4.2. Germany 9.2.4.2.1. Germany Minimally Invasive Surgical Instruments market, By Product, 2020 - 2028 (USD Million) 9.2.4.2.2. Germany Minimally Invasive Surgical Instruments market, By End-User, 2020 - 2028 (USD Million) 9.2.4.2.3. Germany Minimally Invasive Surgical Instruments market, by Region, 2020 - 2028 (USD Million) 9.2.4.3. France 9.2.4.3.1. France Minimally Invasive Surgical Instruments market, By Product, 2020 - 2028 (USD Million) 9.2.4.3.2. France Minimally Invasive Surgical Instruments market, By Region, 2020 - 2028 (USD Million) 9.2.4.3.3. France Minimally Invasive Surgical Instruments market, by End-User, 2020 - 2028 (USD Million) 9.2.4.4. Rest of Europe 9.2.4.4.1. Rest of Europe Minimally Invasive Surgical Instruments market, By Product, 2020 - 2028 (USD Million) 9.2.4.4.2. Rest of Europe Minimally Invasive Surgical Instruments market, By Region, 2020 - 2028 (USD Million) 9.2.4.4.3. Rest of Europe Minimally Invasive Surgical Instruments market, by End-User, 2020 - 2028 (USD Million) 9.3. Asia Pacific 9.3.1. Asia Pacific Minimally Invasive Surgical Instruments market, By Product, 2020 - 2028 (USD Million) 9.3.2. Asia Pacific Minimally Invasive Surgical Instruments market, By End-User, 2020 - 2028 (USD Million) 9.3.5. Asia Pacific Minimally Invasive Surgical Instruments market, by country, 2020 - 2028 (USD Million) 9.3.4.1. China 9.3.4.1.1. China Minimally Invasive Surgical Instruments market, By Product, 2020 - 2028 (USD Million) 9.3.4.1.2. China Minimally Invasive Surgical Instruments market, By Region, 2020 - 2028 (USD Million) 9.3.4.1.3. China Minimally Invasive Surgical Instruments market, by End-User, 2020 - 2028 (USD Million) 9.3.4.2. India 9.3.4.2.1. India Minimally Invasive Surgical Instruments market, By Product, 2020 - 2028 (USD Million) 9.3.4.2.2. India Minimally Invasive Surgical Instruments market, By Region, 2020 - 2028 (USD Million) 9.3.4.2.3. India Minimally Invasive Surgical Instruments market, by End-User, 2020 - 2028 (USD Million) 9.3.4.3. Japan 9.3.4.3.1. Japan Minimally Invasive Surgical Instruments market, By Product, 2020 - 2028 (USD Million) 9.3.4.3.3. Japan Minimally Invasive Surgical Instruments market, by End-User, 2020 - 2028 (USD Million) 9.3.4.4. South Korea 9.3.4.4.1. South Korea Minimally Invasive Surgical Instruments market, By Product, 2020 - 2028 (USD Million) 9.3.4.4.3. South Korea Minimally Invasive Surgical Instruments market, by End-User, 2020 - 2028 (USD Million) 9.3.4.5. Rest of ASIA PACIFIC 9.3.4.5.1. Rest of ASIA PACIFIC Minimally Invasive Surgical Instruments market, By Product, 2020 - 2028 (USD Million) 9.3.4.5.3. Rest of ASIA PACIFIC Minimally Invasive Surgical Instruments market, by End-User, 2020 - 2028 (USD Million) 9.4. Latin America 9.4.1. Latin America Minimally Invasive Surgical Instruments market, By Product, 2020 - 2028 (USD Million) 9.4.3. Latin America Minimally Invasive Surgical Instruments market, by End-User, 2020 - 2028 (USD Million) 9.4.4. Latin America Minimally Invasive Surgical Instruments market, by country, 2020 - 2028 (USD Million) 9.4.4.1. Brazil 9.4.4.1.1. Brazil Minimally Invasive Surgical Instruments market, By Product, 2020 - 2028 (USD Million) 9.4.4.1.3. Brazil Minimally Invasive Surgical Instruments market, by End-User, 2020 - 2028 (USD Million) 9.4.4.2. Mexico 9.4.4.2.1. Mexico Minimally Invasive Surgical Instruments market, By Product, 2020 - 2028 (USD Million) 9.4.4.2.3. Mexico Minimally Invasive Surgical Instruments market, by End-User, 2020 - 2028 (USD Million) 9.4.4.3. Rest of the Latin America 9.4.4.3.1. Rest of the Latin America Minimally Invasive Surgical Instruments market, By Product, 2020 - 2028 (USD Million) 9.4.4.3.3. Rest of the Latin America Minimally Invasive Surgical Instruments market, by End-User, 2020 - 2028 (USD Million) 9.5. MEA 9.5.1. MEA Minimally Invasive Surgical Instruments market, By Product, 2020 - 2028 (USD Million) 9.5.3. MEA Minimally Invasive Surgical Instruments market, by End-User, 2020 - 2028 (USD Million) 10. Competitive Landscape 10.1 Medtronic plc. 10.1.1. Company overview 10.1.2. Financial performance 10.1.3. Product Portfolio Analysis 10.1.4. Business Strategy & Recent Development 10.2. Stryker Corporation. 10.2.1. Company overview 10.2.2. Financial performance 10.2.3. Product Portfolio Analysis 10.2.4. Business Strategy & Recent Development 10.3. Johnson & Johnson. 10.3.1. Company overview 10.3.2. Financial performance 10.3.3. Product Portfolio Analysis 10.3.4. Business Strategy & Recent Development 10.4. Smith & Nephew plc. 10.4.1. Company overview 10.4.2. Financial performance 10.4.3. Product Portfolio Analysis 10.4.4. Business Strategy & Recent Development 10.5. Abbott Laboratories, Inc 10.5.1. Company overview 10.5.2. Financial performance 10.5.3. Product Portfolio Analysis 10.5.4. Business Strategy & Recent Development 10.6. B. Braun Melsungen AG. 10.6.1. Company overview 10.6.2. Financial performance 10.6.3. Product Portfolio Analysis 10.6.4. Business Strategy & Recent Development 10.7. CONMED Corporation. 10.7.1. Company overview 10.7.2. Financial performance 10.7.3. Product Portfolio Analysis 10.7.4. Business Strategy & Recent Development 10.8. Boston Scientific Corporation 10.8.1. Company overview 10.8.2. Financial performance 10.8.3. Product Portfolio Analysis 10.8.4. Business Strategy & Recent Development 10.9. Zimmer Biomet Holdings, Inc. 10.9.1. Company overview 10.9.2. Financial performance 10.9.3. Product Portfolio Analysis 10.9.4. Business Strategy & Recent Development 10.10. Becton, Dickinson and Company. 10.10.1. Company overview 10.10.2. Financial performance 10.10.3. Product Portfolio Analysis 10.10.4. Business Strategy & Recent Development 10.11. The Cooper Companies Inc. 10.11.1. Company overview 10.11.2. Financial performance 10.11.3. Product Portfolio Analysis 10.11.4. Business Strategy & Recent Development 10.12. HOYA Corporation. 10.12.1. Company overview 10.12.2. Financial performance 10.12.3. Product Portfolio Analysis 10.12.4. Business Strategy & Recent Development 10.13. Surgical Innovations Group plc. 10.13.1. Company overview 10.13.2. Financial performance 10.13.3. Product Portfolio Analysis 10.13.4. Business Strategy & Recent Development 10.14. Koninklijke Philips N.V.. 10.14.1. Company overview 10.14.2. Financial performance 10.14.3. Product Portfolio Analysis 10.14.4. Business Strategy & Recent Development 10.15. FUJIFILM Holdings Corporation. 10.15.1. Company overview 10.15.2. Financial performance 10.15.3. Product Portfolio Analysis 10.15.4. Business Strategy & Recent Development 10.16. KARL STORZ SE & Co. KG. 10.16.1. Company overview 10.16.2. Financial performance 10.16.3. Product Portfolio Analysis 10.16.4. Business Strategy & Recent Development 10.17. Applied Medical Resources Corporation. 10.17.1. Company overview 10.17.2. Financial performance 10.17.3. Product Portfolio Analysis 10.17.4. Business Strategy & Recent Development 10.18. STRAUSS SURGICAL. 10.18.1. Company overview 10.18.2. Financial performance 10.18.3. Product Portfolio Analysis 10.18.4. Business Strategy & Recent Development 10.19. KLS Martin Group. 10.19.1. Company overview 10.19.2. Financial performance 10.19.3. Product Portfolio Analysis 10.19.4. Business Strategy & Recent Development 10.20. Scanlan International, Inc. 10.20.1. Company overview 10.20.2. Financial performance 10.20.3. Product Portfolio Analysis 10.20.4. Business Strategy & Recent Development 10.21. TROKAMED GmbH . 10.21.1. Company overview 10.21.2. Financial performance 10.21.3. Product Portfolio Analysis 10.21.4. Business Strategy & Recent Development 10.22. Wexler Surgical. 10.22.1. Company overview 10.22.2. Financial performance 10.22.3. Product Portfolio Analysis 10.22.4. Business Strategy & Recent Development 10.23. AMNOTEC International Medical GmbH. 10.23.1. Company overview 10.23.2. Financial performance 10.23.3. Product Portfolio Analysis 10.23.4. Business Strategy & Recent Development 10.24. EndoMed Systems GmbH. 10.24.1. Company overview 10.24.2. Financial performance 10.24.3. Product Portfolio Analysis 10.24.4. Business Strategy & Recent Development 10.25. Surgical Holdings. 10.25.1. Company overview 10.25.2. Financial performance 10.25.3. Product Portfolio Analysis 10.25.4. Business Strategy & Recent Development List of Tables (83 Tables) TABLE 1. Minimally Invasive Surgical Instruments MARKET, By Product, 2020-2028 (USD Million) TABLE 2. Minimally Invasive Surgical Instruments MARKET FOR Handheld Instruments, BY REGION, 2020-2028 (USD Million) TABLE 3. Minimally Invasive Surgical Instruments MARKET FOR Cutting Instruments, BY REGION, 2020-2028 (USD Million) TABLE 4. Minimally Invasive Surgical Instruments MARKET FOR Inflation Devices, BY REGION, 2020-2028 (USD Million) TABLE 5. Minimally Invasive Surgical Instruments MARKET FOR Electrosurgical & Electrocautery Instruments, BY REGION, 2020-2028 (USD Million) TABLE 6. Minimally Invasive Surgical Instruments MARKET FOR Guiding Devices, BY REGION, 2020-2028 (USD Million) TABLE 7. Minimally Invasive Surgical Instruments MARKET FOR Others, BY REGION, 2020-2028 (USD Million) TABLE 8. Minimally Invasive Surgical Instruments MARKET, By Surgery Type, 2020-2028 (USD Million) TABLE 9. Minimally Invasive Surgical Instruments MARKET FOR Cardiothoracic Surgery, BY REGION, 2020-2028 (USD Million) TABLE 10. Minimally Invasive Surgical Instruments MARKET FOR Orthopaedic Surgery, BY REGION, 2020-2028 (USD Million) TABLE 11. Minimally Invasive Surgical Instruments MARKET FOR Gastrointestinal Surgery, BY REGION, 2020-2028 (USD Million) TABLE 12. Minimally Invasive Surgical Instruments MARKET FOR Cosmetic Surgery, BY REGION, 2020-2028 (USD Million) TABLE 13. Minimally Invasive Surgical Instruments MARKET FOR Gynaecological Surgery, BY REGION, 2020-2028 (USD Million) TABLE 14. Minimally Invasive Surgical Instruments MARKET FOR Urological Surgery, BY REGION, 2020-2028 (USD Million) TABLE 15. Minimally Invasive Surgical Instruments MARKET FOR Others, BY REGION, 2020-2028 (USD Million) TABLE 16. Minimally Invasive Surgical Instruments MARKET, BY END-USER, 2020-2028 (USD Million) TABLE 17. Minimally Invasive Surgical Instruments MARKET FOR Hospitals and Speciality Clinics, BY REGION, 2020-2028 (USD Million) TABLE 18. Minimally Invasive Surgical Instruments MARKET FOR Ambulatory Surgery Centers (ASCs), BY REGION, 2020-2028 (USD Million) TABLE 19. Minimally Invasive Surgical Instruments MARKET FOR Others, BY REGION, 2020-2028 (USD Million) TABLE 20. Minimally Invasive Surgical Instruments MARKET, BY REGION, 2020-2028 (USD Million) TABLE 21. NORTH AMERICA Minimally Invasive Surgical Instruments MARKET, BY COUNTRY, 2020-2028 (USD Million) TABLE 22. NORTH AMERICA Minimally Invasive Surgical Instruments MARKET, BY End-Users, 2020-2028 (USD Million) TABLE 23. NORTH AMERICA Minimally Invasive Surgical Instruments MARKET, By Product, 2020-2028 (USD Million) TABLE 24. NORTH AMERICA Minimally Invasive Surgical Instruments MARKET, BY END-USER, 2020-2028 (USD Million) TABLE 25. EUROPE Minimally Invasive Surgical Instruments MARKET, BY COUNTRY, 2020-2028 (USD Million) TABLE 26. EUROPE Minimally Invasive Surgical Instruments MARKET, By Product, 2020-2028 (USD Million) TABLE 27. EUROPE Minimally Invasive Surgical Instruments MARKET, BY END-USER, 2020-2028 (USD Million) TABLE 28. ASIA-PACIFIC Minimally Invasive Surgical Instruments MARKET, BY COUNTRY, 2020-2028 (USD Million) TABLE 29. ASIA-PACIFIC Minimally Invasive Surgical Instruments MARKET, By Product, 2020-2028 (USD Million) TABLE 30. ASIA-PACIFIC Minimally Invasive Surgical Instruments MARKET, BY END-USER, 2020-2028 (USD Million) TABLE 31. LAMEA Minimally Invasive Surgical Instruments MARKET, BY COUNTRY, 2020-2028 (USD Million) TABLE 32. LAMEA Minimally Invasive Surgical Instruments MARKET, By Product, 2020-2028 (USD Million) TABLE 33. LAMEA Minimally Invasive Surgical Instruments MARKET, BY END-USER, 2020-2028 (USD Million) TABLE 34. Medtronic plc: COMPANY SNAPSHOT TABLE 35. Medtronic plc: OPERATING SEGMENTS TABLE 36. Stryker Corporation.: COMPANY SNAPSHOT TABLE 37. Stryker Corporation: OPERATING SEGMENTS TABLE 38. Johnson & Johnson : COMPANY SNAPSHOT TABLE 39. Johnson & Johnson : OPERATING SEGMENTS TABLE 40. Smith & Nephew plc: COMPANY SNAPSHOT TABLE 41. Smith & Nephew plc: OPERATING SEGMENTS TABLE 42. Abbott Laboratories, Inc: COMPANY SNAPSHOT TABLE 43. Abbott Laboratories, Inc: OPERATING SEGMENTS TABLE 44. B. Braun Melsungen AG: COMPANY SNAPSHOT TABLE 45. B. Braun Melsungen AG: OPERATING SEGMENTS TABLE 46. CONMED Corporation: COMPANY SNAPSHOT TABLE 47. CONMED Corporation: OPERATING SEGMENTS TABLE 48. Boston Scientific Corporation: COMPANY SNAPSHOT TABLE 49. Boston Scientific Corporation: OPERATING SEGMENTS TABLE 50. Zimmer Biomet Holdings, Inc: COMPANY SNAPSHOT TABLE 51. Zimmer Biomet Holdings, Inc: OPERATING SEGMENTS TABLE 52. Becton, Dickinson and Company: COMPANY SNAPSHOT TABLE 53. Becton, Dickinson and Company: OPERATING SEGMENTS TABLE 54. The Cooper Companies Inc: COMPANY SNAPSHOT TABLE 55. The Cooper Companies Inc: OPERATING SEGMENTS TABLE 56. HOYA Corporation: COMPANY SNAPSHOT TABLE 57. HOYA Corporation: OPERATING SEGMENTS TABLE 58. Surgical Innovations Group plc: COMPANY SNAPSHOT TABLE 59. Surgical Innovations Group plc: OPERATING SEGMENTS TABLE 60. Koninklijke Philips N.V.: COMPANY SNAPSHOT TABLE 61. Koninklijke Philips N.V.: OPERATING SEGMENTS TABLE 62. FUJIFILM Holdings Corporation: COMPANY SNAPSHOT TABLE 63. FUJIFILM Holdings Corporation: OPERATING SEGMENTS TABLE 64. KARL STORZ SE & Co. KG: COMPANY SNAPSHOT TABLE 65. KARL STORZ SE & Co. KG: OPERATING SEGMENTS TABLE 66. Applied Medical Resources Corporation: COMPANY SNAPSHOT TABLE 67. Applied Medical Resources Corporation: OPERATING SEGMENTS TABLE 68. STRAUSS SURGICAL: COMPANY SNAPSHOT TABLE 69. STRAUSS SURGICAL: OPERATING SEGMENTS TABLE 70. KLS Martin Group: COMPANY SNAPSHOT TABLE 71. KLS Martin Group: OPERATING SEGMENTS TABLE 72. Scanlan International, Inc: COMPANY SNAPSHOT TABLE 73. Scanlan International, Inc: OPERATING SEGMENTS TABLE 74. TROKAMED GmbH: COMPANY SNAPSHOT TABLE 75. TROKAMED GmbH: OPERATING SEGMENTS TABLE 76. Wexler Surgical: COMPANY SNAPSHOT TABLE 77. Wexler Surgical: OPERATING SEGMENTS TABLE 78. AMNOTEC International Medical GmbH: COMPANY SNAPSHOT TABLE 79. AMNOTEC International Medical GmbH: OPERATING SEGMENTS TABLE 80. EndoMed Systems GmbH: COMPANY SNAPSHOT TABLE 81. EndoMed Systems GmbH: OPERATING SEGMENTS TABLE 82. Surgical Holdings: COMPANY SNAPSHOT TABLE 83. Surgical Holdings: OPERATING SEGMENTS List of Figures (22 Figures) Figure 1 Minimally Invasive Surgical Instruments Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Minimally Invasive Surgical Instruments Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Minimally Invasive Surgical Instruments Market: Product-Based Estimation Figure 6 Top 25 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Minimally Invasive Surgical Instruments, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Minimally Invasive Surgical Instruments, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Minimally Invasive Surgical Instruments Market, By End-Users, 2019 vs. 2025 (USD Million) Figure 12 Minimally Invasive Surgical Instruments Market, By Surgery Type, 2019 vs. 2025 (USD Million) Figure 13 Minimally Invasive Surgical Instruments Market Share, By Product, 2019 vs. 2025 Figure 14 Geographical Snapshot of the Minimally Invasive Surgical Instruments Market Figure 15 Handheld Instruments to Witness Higher CAGR in Minimally Invasive Surgical Instruments Market for Product Segment during Forecast Period. Figure 16 Hospitals and Speciality Clinics to Witness Higher CAGR in Minimally Invasive Surgical Instruments Market for End-User Segment during Forecast Period. Figure 17 Cardiothoracic Surgery to Witness Higher CAGR in Minimally Invasive Surgical Instruments Market for Surgery Type Segment during Forecast Period. Figure 18 North America Accounted for the Largest Share of the Minimally Invasive Surgical Instruments Market, By Regional Basis, in 2019 Figure 19 Minimally Invasive Surgical Instruments Market: Drivers, Restraints, Opportunities, and Challenges Figure 20 Europe: Minimally Invasive Surgical Instruments Market Snapshot Figure 21 Asia Pacific: Minimally Invasive Surgical Instruments Market Snapshot Figure 22 Vendor Dive: Evaluation Overview